Navigation Links
Orqis(R) Medical's MOMENTUM Trial Abstract Accepted for Late Breaking Clinical Trial Presentation at the American College of Cardiology Annual Meeting
Date:2/13/2008

Investigators to Report use of the Cancion(R) System in Patients

Hospitalized with Heart Failure

LAKE FOREST, Calif., Feb. 13 /PRNewswire/ -- Orqis(R) Medical Corporation, a medical products company developing and marketing devices to treat heart failure, announced today that the company's MOMENTUM Trial Abstract was accepted for Late Breaking Clinical Trial presentation at the upcoming annual American College of Cardiology (ACC) meeting in Chicago. The MOMENTUM Trial evaluated the percutaneous Cancion System in patients with acute decompensated heart failure.

Barry Greenberg, M.D., Director, Advanced Heart Failure Treatment Program, University of California San Diego Medical Center, and National Principal Investigator for the MOMENTUM Trial, will present, "Efficacy and Safety of Continuous Aortic Flow Augmentation in Patients Hospitalized with Acute Decompensated Heart Failure: Results of the MOMENTUM Trial," Tuesday, April 1, 2008, from 1:45 pm to 2:00 pm, at the McCormick Place convention center, North Hall B1.

"MOMENTUM is a landmark study examining the hemodynamic and clinical effects of the Cancion System in managing patients hospitalized with heart failure inadequately responsive to medical therapy," stated Dr. Barry Greenberg. Mr. Ken Charhut, President and CEO added, "We are delighted that the MOMENTUM Trial Abstract has been accepted for presentation at the ACC conference and look forward to Dr Greenberg's presentation and dialogue."

About Heart Failure

Over 5 million Americans suffer from heart failure, a condition in which the heart becomes weakened and cannot pump blood efficiently. Heart failure is caused by coronary artery disease, past myocardial infarctions, cardiomyopathy and other underlying cardiovascular disorders, and it is characterized by shortness of breath, functional impairment, and edema. In the U.S., heart failure results in over 1 million hospitalizations annually and i
'/>"/>

SOURCE Orqis Medical Corporation
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Hooper Holmes Concludes Sale of Medicals Direct
2. Long Term Care Insurance Gains Momentum Thanks to State Promotions, a Leading Brokerage Reports
3. Black AIDS Mobilization Gains Momentum with Congressional Black Caucus Call to Action
4. Eclipsys Announces Strong Market Momentum for Sunrise Pharmacy
5. World Cancer Campaign Builds Momentum Globally with International Initiative to Protect Children From Secondhand Smoke
6. New Heart Pump Shows Promise in Trial
7. Trial to Test Gene Therapy for Angina in Women
8. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
9. The New England Journal of Medicine Publishes EURIDIS/ADONIS Study Results Showing Dronedarone Maintained Sinus Rhythm in Patients With Atrial Fibrillation or Flutter With no Observed Pro-Arrhythmia
10. Provectus Pharmaceuticals, Inc. Begins Phase 2 Clinical Trial for Metastatic Melanoma
11. MDS Pharma Services Wins Award for Management of Global Malaria Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2008)...PRNewswire/ -- WXYZ- TV/Channel 7 and The,Detroit ...ive thousands of,Detroit metro area children a "bo...program. This year the program will be held Sunday...arles H. Wright Museum of African,American History... Kids",has provided free immunizations to over 50,...
(Date:8/20/2008)...re/ -- Fourteen physicians who have been,part of C... plan to enhance,the care and service they provide... "These are top-notch primary care physicians, an...rganization," said Nick Turkal, M.D., Aurora,s,pre...rd to working with,them to support their care of p...
(Date:8/20/2008)...deadly traitors, good cells gone bad. They evade t...as organisms that pose no threat. , But research...Hill,s Eshelman School of Pharmacy are working on ...an associate professor of molecular pharmaceutics,...cterial elements in a cancer tumor in order to enc...
(Date:8/20/2008)...ire-USNewswire/ -- Yesterday evening,Congresswoma...ital after,suffering an aneurysm while driving her...me Rep. Tubbs Jones, condition has stabilized and ...y,s condition followed a full day of activity, inc... reform, scheduled for September 4, 2008,at Clevel...
Breaking Medicine News(10 mins):Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 2Health News:WXYZ-TV/Channel 7 is 'On Your Side' With Healthy Living For Kids; Free Immunizations for Children on Sunday, August 24 at Charles H. Wright Museum of African American History 3Health News:Commonwealth Medical Group Physicians to Join Aurora Health Care 2Health News:UNC researcher aims to 'unmask' cancer cells to trigger body's immune system 2
...en living under polluted, hazy skies move away to...o grow more quickly, according to a study by resea...ntive medicine researchers followed more than 100 ...ose who moved away to other communities in the Wes...
...study has found gardening is the best form of exer...y Dr Sara Fenn and colleagues at the University of...0,000 women, including more than 3,000 aged 50 yea... gardened at least once a week showed higher bone ...
...tion of two targeted drug therapies results in dra...tro, indicating a potentially powerful new approac... – trastuzumab and ZD1839 were found to work syner...o different growth factors receptors, HER2 and epi...
...tyrosinemia type 1( HT-1) is a genetic metabolic d...liver cancer in young children. It's a very rare d...hat all newborns are tested for at birth, so often...bsolutely fatal disease until now. Children born w...
Other Medicine News:Health News:Particulate matter affects lung development 2
(Date:8/18/2008)...-USNewswire/ -- Boston University and Aubrey,Milun...uman Genetics, Inc.,("CHG") and Director of the Ce...unced that CHG will no longer offer testing servic...cs, Inc., These patented tests include tests rela...r Connexin 26 mutations, developmental disorders c...
(Date:8/18/2008)...ls Phase of Test Development Program, ORANGE COUN...man,Coulter, Inc. (NYSE: BEC ) announced today th...lty obligation to Nephromics LLC, a Chestnut Hill,...e license is for tests,related to the detection, m...eading cause of maternal death. In addition, Beckm...
(Date:8/18/2008)...ewswire-FirstCall/ -- Micromet, Inc.,(Nasdaq: MIT... proprietary,antibodies for the treatment of cance... a webcast and conference call this morning, Monda...00 p.m. Central European,Time) to discuss the blin...CIENCE on August 15, 2008., To access the webcast...
(Date:8/14/2008)...ire-FirstCall/ -- AstraZeneca (NYSE: AZN ),today ...ational Cancer,Centre Singapore (NCCS) and the Nat...ncer compounds. The collaboration, which is spelt ...s signed today, aims to further,build AstraZeneca,...tely,speed up access to new medicines of potential...
Breaking Medicine Technology:Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 2Beckman Coulter Buys Out Royalty Obligation for Preeclampsia Markers 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 2Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 3Micromet, Inc. to Host Webcast and Conference Call to Discuss Blinatumomab Data Published in SCIENCE 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 2AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 3AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 4AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 5AstraZeneca Announces Innovative New Partnership With Singapore Institutions to Develop Anti-Cancer Compounds 6International Association of Forensic Nurses Announces their 2007 Award Winners 6977 1International Association of Forensic Nurses Announces their 2007 Award Winners 6977 2Stem cells train heart following heart attack 6973 1Undocumented Hispanics Less Likely to Use U S Health Care Services 6972 1Undocumented Hispanics Less Likely to Use U S Health Care Services 6972 2Oncolytics Biotech Inc Announces Issuance of 24th U S Patent 1961 1Oncolytics Biotech Inc Announces Issuance of 24th U S Patent 1961 2
...swire-FirstCall/ --,Medivation, Inc. today announc... Eastern time on Monday, June 11, to discuss top-l...lind,placebo-controlled Phase 2 clinical trial of...imer,s disease. , Rachelle Doody, M.D., Ph.D., lea...month results for the first time at a,scientific m...
...SS WIRE)--Jun 7, 2007 - As a,follow up to ProtoKin...e related to cryopreserved (or frozen) cells treat...sity of Helsinki,Finland, ProtoKinetix has recent...whether AAGP(TM) treated cells could survive,after...menting on the results, ProtoKinetix,s Director of...
Other Medicine Technology:Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 2Medivation to Host Conference Call to Discuss Top-Line 12-Month,Results From Dimebon Alzheimer's Disease Study 3Refrigerated Stem Cells Survive 12 Times Longer with ProtoKinetix's,AAGP 2
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: